These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study]. Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560 [TBL] [Abstract][Full Text] [Related]
23. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
24. Contingent triple-screening for Down syndrome in the second trimester is not a cost-effective prenatal screening strategy in Mainland Chinese population. Li DZ Prenat Diagn; 2010 May; 30(5):493. PubMed ID: 20440741 [No Abstract] [Full Text] [Related]
25. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244 [TBL] [Abstract][Full Text] [Related]
26. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Hsu JJ; Hsieh TT; Soong YK; Spencer K Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893 [TBL] [Abstract][Full Text] [Related]
27. Comparison of first-trimester contingent screening strategies for Down syndrome. Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chen M; Lau TK Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660 [TBL] [Abstract][Full Text] [Related]
28. First trimester, second trimester, and integrated screening for Down's syndrome in China. Miao ZY; Liu X; Shi TK; Xu Y; Song QH; Tang SH J Med Screen; 2012 Jun; 19(2):68-71. PubMed ID: 22653574 [TBL] [Abstract][Full Text] [Related]
29. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome. Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446 [TBL] [Abstract][Full Text] [Related]
30. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
31. An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Christiansen M; Olesen Larsen S Prenat Diagn; 2002 Jun; 22(6):482-6. PubMed ID: 12116307 [TBL] [Abstract][Full Text] [Related]
32. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125 [TBL] [Abstract][Full Text] [Related]
33. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572 [TBL] [Abstract][Full Text] [Related]
34. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province]. Hu YL; Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809 [TBL] [Abstract][Full Text] [Related]
35. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Cuckle HS; Holding S; Jones R Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963 [TBL] [Abstract][Full Text] [Related]
36. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Biggio JR; Morris TC; Owen J; Stringer JS Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005 [TBL] [Abstract][Full Text] [Related]
37. [Correlation of free fetal DNA with beta-human chorionin gonadotropin in circulation in pregnant women with high risk of Down's syndrome]. Meng JL; Wang XT; Chen ZJ Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):661-4. PubMed ID: 20079176 [TBL] [Abstract][Full Text] [Related]
39. [Second trimester Down syndrome serum screening--results from a pilot study]. Dimitrova V; Chernev T; Kremenski I; Mazneĭkova V; Mikhaĭlova E; Simeonov E; Tincheva R; Toncheva D Akush Ginekol (Sofiia); 2002; 41(2):3-12. PubMed ID: 12066548 [TBL] [Abstract][Full Text] [Related]
40. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]